PR Newswire PharmaOriginal article
Study Finds Some Medical Spas Still Selling Compounded Weight-Loss Drugs From Pharmacies With Regulatory Concerns
GLP-1Negative
AI Analysis
Summary
CU Anschutz researchers found that some medical spas continue selling compounded GLP-1 weight-loss drugs from pharmacies lacking sterile compounding licenses or with disciplinary histories, despite the end of federal FDA shortages.
Importance:3/10
Sentiment:
-0.60
regulatory concernscompounding pharmaciesGLP-1 drugsmedical spasFDA oversight
Read the original article
Published by PR Newswire Pharma on July 17, 2026 3:15 PM
